SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001789769-23-000095
Filing Date
2023-11-27
Accepted
2023-11-27 07:13:52
Documents
12
Period of Report
2023-11-21
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K til-20231121.htm   iXBRL 8-K 30162
  Complete submission text file 0001789769-23-000095.txt   158773

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20231121.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20231121_lab.xml EX-101.LAB 24833
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20231121_pre.xml EX-101.PRE 13038
6 EXTRACTED XBRL INSTANCE DOCUMENT til-20231121_htm.xml XML 2804
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

IRS No.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 231437313
SIC: 2836 Biological Products, (No Diagnostic Substances)